Variant report
Variant | nsv969279 |
---|---|
Chromosome Location | chr5:15256386-15259548 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545066273 | chr5:15256395-15256396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76903394 | chr5:15256398-15256399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530863192 | chr5:15256407-15256408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536929805 | chr5:15256425-15256426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140967570 | chr5:15256455-15256456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144781669 | chr5:15256534-15256535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs56217334 | chr5:15256579-15256580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183889830 | chr5:15256587-15256588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576702693 | chr5:15256599-15256600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547585083 | chr5:15256600-15256601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565877517 | chr5:15256621-15256622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539543410 | chr5:15256637-15256638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188666756 | chr5:15256671-15256672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79534775 | chr5:15256675-15256676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537365984 | chr5:15256682-15256683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555978543 | chr5:15256710-15256711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544040394 | chr5:15256731-15256732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574160940 | chr5:15256758-15256759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563675797 | chr5:15256786-15256787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181488910 | chr5:15256809-15256810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138428377 | chr5:15256817-15256818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577837445 | chr5:15256820-15256821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572145181 | chr5:15256836-15256837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34183693 | chr5:15256869-15256870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78713784 | chr5:15256878-15256879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78653137 | chr5:15256879-15256880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs397738553 | chr5:15256880-15256881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75613188 | chr5:15256882-15256883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545106344 | chr5:15256892-15256893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563290703 | chr5:15256893-15256894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148854626 | chr5:15256901-15256902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529619910 | chr5:15256909-15256910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143517849 | chr5:15256944-15256945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184477817 | chr5:15256985-15256986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543052049 | chr5:15256998-15256999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561219973 | chr5:15257000-15257001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190379101 | chr5:15257009-15257010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546437490 | chr5:15257021-15257022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182212279 | chr5:15257061-15257062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577282637 | chr5:15257122-15257123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564717051 | chr5:15257125-15257126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547383321 | chr5:15257131-15257132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77635429 | chr5:15257183-15257184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529183003 | chr5:15257189-15257190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147976385 | chr5:15257208-15257209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528814653 | chr5:15257312-15257313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187213017 | chr5:15257331-15257332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34454075 | chr5:15257340-15257341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537411313 | chr5:15257376-15257377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368162791 | chr5:15257385-15257386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 21364760 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:15250600-15259000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr5:15254600-15256400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr5:15254800-15256800 | Enhancers | Fetal Lung | lung |
4 | chr5:15255600-15260200 | Weak transcription | Aorta | Aorta |
5 | chr5:15256200-15256400 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr5:15256400-15259000 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr5:15256800-15259400 | Weak transcription | Fetal Lung | lung |
8 | chr5:15258000-15258200 | Enhancers | Fetal Heart | heart |
9 | chr5:15258200-15259400 | Weak transcription | Fetal Heart | heart |
10 | chr5:15259000-15262000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr5:15259000-15262600 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr5:15259400-15260800 | Enhancers | Fetal Lung | lung |
13 | chr5:15259400-15262600 | Enhancers | Fetal Heart | heart |